Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
mycosis fungoides/adenosina
L'enllaç es desa al porta-retalls
13 resultats
Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Adenosine deaminase activities in sera were measured in 18 psoriatic patients, 8 mycosis fungoides patients, and 9 patients with adult T cell leukemia. Adenosine deaminase activity in the sera of the psoriatic patients showed no significant increase. An elevated adenosine deaminase activity was
Clinical significance of serum adenosine deaminase activity in patients with mycosis fungoides.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Adenosine deaminase is one of the key enzymes in purine nucleotide degradation. This enzyme exists in most of the human tissues and the activity is high in lymphatic tissues, especially in T lymphocytes. Elevated adenosine deaminase activity in T cell leukemia has been reported, and its inhibitor,
Normal serum adenosine deaminase activity in mycosis fungoides.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OBJECTIVE
To review recent studies of systemic therapy for mycosis fungoides and the Sézary syndrome (cutaneous T-cell lymphomas).
METHODS
English-language articles indexed in MEDLINE from 1988 through 1994.
METHODS
All therapeutic studies were selected.
METHODS
The data were abstracted without
[Identification of Langerhans cells in dermatology].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This paper describes our own findings on the role of Langerhans' cells in dermatology and discusses literature data on their detection in seven different dermatoses. The skin is an integral part of immune system. During the past 30 years, increasing evidence has been accumulated that the skin
Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The cutaneous T-cell lymphomas (CTCL) comprise a heterogeneous group of entities. The WHO classification distinguishes indolent low-risk entities, including mycosis fungoides/Sézary syndrome (MF/SS), from aggressive entities, including peripheral T-cell lymphoma and its variants and HTLV-1
Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Promising results in the treatment of indolent lymphomas have been reported with the use of 2'deoxycoformycin. This antimetabolite, an adenosine deaminase inhibitor, also shows particular efficacy in hairy cell leukemia. Of 65 patients treated to date, 44 have achieved complete and lasting remission
Pentostatin treatment of cutaneous T-cell lymphoma.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Mycosis fungoides is an indolent primary cutaneous T-cell lymphoma (CTCL) that usually progresses from localized skin lesions to systemic disease. Sézary syndrome is a distinct variant characterized by generalized erythroderma and circulating cerebriform cells in the peripheral blood. The malignant
Clinical pharmacology of deoxycoformycin.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Deoxycoformycin (DCF) is an inhibitor of adenosine deaminase (ADA). Twenty-one courses of DCF were administered to 13 patients ranging in age from 15 to 78 yr. Eight patients had T-cell disorders, and five patients had non-T-cell malignancies. The i.v. bolus dose was escalated from 5 to 30 mg/sq
2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
A new antimetabolite, 2'-deoxycoformycin (pentostatin), has striking antitumor activity in several lymphoid neoplasms. Isolated from cultured soil organisms, this purine analogue is a potent inhibitor of adenosine deaminase (ADA), and is thus selectively toxic to lymphocytes. Early clinical trials
Efficacy of methotrexate as anti-inflammatory and anti-proliferative drug in dermatology: Three case reports.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Methotrexate (MTX) is a folic acid analog with anti-proliferative (anti-neoplastic, cytotoxic), immunosuppressive and anti-inflammatory properties, which has been used in the treatment of various cutaneous disorders, such as psoriasis, keratoacanthoma, pityriasis rubra pilaris, atopic dermatitis,
Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Fludarabine phosphate is the 2-fluoro, 5'-monophosphate derivative of vidarabine (ara-A) with the advantages of resistance to deamination by adenosine deaminase (ADA) and improved solubility. The mechanism of cytotoxic action of the compound appears to involve metabolic conversion to the active
An investigation of 2'-deoxycoformycin in the treatment of cutaneous T-cell lymphoma.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
We have investigated the use of 2'-deoxycoformycin (DCF), a potent inhibitor of adenosine deaminase (ADA), in the treatment of 4 patients with advanced mycosis fungoides (MF). Since DCF has demonstrated an adverse effect in vitro and in vivo on the survival of leukemia T-cell lines, it appeared
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
